EC Number |
Inhibitors |
Structure |
---|
2.3.1.50 | (2S,3R)-2-amino-12-hydroxy-2-hydroxymethyl-3-sulfooxy-octadecanoic acid |
IC50: 5.4 nM |
|
2.3.1.50 | (2S,3R)-2-amino-12-[(Z)-hydroxyimino]-2-hydroxymethyl-3-sulfooxy-octadecanoic acid |
IC50: 30 nM |
|
2.3.1.50 | (2S,3R)-2-amino-3,12-dihydroxy-2-hydroxymethyl-octadecanoic acid |
IC50: 3.2 nM |
|
2.3.1.50 | (2S,3R)-2-amino-3-hydroxy-2-hydroxymethyl-12-oxo-octadecanoic acid |
IC50: 3.5 nM |
|
2.3.1.50 | (2S,3R)-2-amino-3-hydroxy-2-hydroxymethyl-12-oxo-octadecanoic acid methyl ester |
IC50: 17 nM |
|
2.3.1.50 | 2-chloro-N-[(7S)-4-(3,4-dimethoxybenzoyl)-1-(propan-2-yl)-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-b]pyridin-7-yl]benzamide |
- |
|
2.3.1.50 | 3-hydroxypropionate |
competitive to L-serine |
|
2.3.1.50 | 4-amino-3-isoxazolidone |
D-cycloserine and L-cycloserine are inhibitors, L-cycloserine is 14-fold more effective than D-cycloserine |
|
2.3.1.50 | alpha-methyl-DL-serine |
competitive to L-serine |
|
2.3.1.50 | beta-chloro-L-alanine |
- |
|